Drug trials exported to emerging markets
Wednesday, March 9, 2005
Western drugmakers are shifting more clinical trials to emerging markets in a bid to save money, speed research and educate a new generation of local doctors about their products. Just how far the trend has gone was highlighted on Wednesday when Sanofi-Aventis SA, Bristol-Myers Squibb Co and AstraZeneca Plc announced results from a 46,000-patient trial of two drugs in China.
Story found here.